retatrutide study news 🚨Breaking: Retatrutide's first Phase 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Eli Lilly releases new data

For Jody Dushay, an endocrinologist at Beth Israel Deaconess Medical Center and an Assistant Professor of Medicine at Harvard Medical School, the current moment feels both exhilarating and unsettling

And for the positive side, our guide to what to eat on tirzepatide provides meal suggestions that minimize GI discomfort while maximizing nutrition

What safeguards reduce errors

Supports insulin function and glucose balance

Exendin-4 therapy still offered an additional benefit on reducing transverse aortic constriction-induced cardiac hypertrophy-caused myocardial damage in DPP-4 deficient rats

Some lose a lot of weight and control their blood sugar better